A.A. Noujaim - Concepedia

Author

A.A. Noujaim

Also Known As

A A Noujaim, A. A. NOUJAIM, A. A. Noujaim, A. Noujaim, A.A Noujaim, A.A. NOUJAIM, A.A. Noujaim, ANTOINE A. NOUJAIM, Antoine A Noujaim, Antoine A. Noujaim

119

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Alberta Alberta Hospital Edmonton Goethe University Frankfurt University of Alberta Hospital

About

A.A. Noujaim is an author at University of Alberta specializing in medicine, immunology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	849
2	Biochemistry	7	7	110
3	Health Sciences	4	4	70
4	Natural Sciences	4	4	79
5	Engineering	3	3	36

A.A. Noujaim

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Induction of CA125-Specific B and T Cell Responses in Patients Injected with MAb-B43.13—Evidence for Antibody-Mediated Antigen-Processing and Presentation of CA125 in Vivo A.A. Noujaim, Birgit C. Schultes, Richard P. Baum, Cancer Biotherapy and Radiopharmaceuticals Immunocytochemical TechniqueT Cell ResponsesImmunologyCa125-specific BPathology	2001	110
Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma R. P. Baum, A. Niesen, A. Hertel, Cancer Immunocytochemical TechniqueImmunologyPathologyImmunophenotypingImmunotherapy	1994	77
Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer Volker Möbus, Richard P. Baum, Marcus Bolle, American Journal of Obstetrics and Gynecology Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityGynecology	2003	65
Analysis of human tumor associated Thomsen-Friedenreich antigen. John Samuel, A.A. Noujaim, Grant D. MacLean, PubMed Immunocytochemical TechniqueImmunologyImmunoeditingPathologyImmunodominance	1990	41
Iatrogenic alterations in radionuclide biodistributions Brian C. Lentle, John R. Scott, A.A. Noujaim, Seminars in Nuclear Medicine Radionuclide TherapyPathologyRadiopharmaceuticalsRadioanalytical ChemistryRadiopharmaceutical Therapy	1979	41
Antiidiotype Induction Therapy: Evidence for the Induction of Immune Response through the Idiotype Network in Patients with Ovarian Cancer after Administration of Anti-CA 125 Murine Monoclonal Antibody B43.13 Ragupathy Madiyalakan, T.R. Sykes, S. Dharampaul, Hybridoma	1995	40
Clinical Course of Ovarian Cancer Patients Under Repeated Stimulation of HAMA Using MAb OC125 and B43.13 Richard P. Baum, A.A. Noujaim, Andreea A. Nanci, Hybridoma Clinical CourseMedicineGynecologyCancer TreatmentOncology	1993	39
Monoclonal antibody against a cryptic carbohydrate antigen of murine and human lymphocytes. I. antigen expression in non‐cryptic or unsubstituted form on certain murine lymphomas, on a spontaneous murine mammary carcinoma, and on several human adenocarcinomas B. Michael Longenecker, Amaly Rahman, J. Barrington Leigh, International Journal of Cancer	1984	37
Immunotherapy of Human Ovarian Carcinoma with OVAREX <sup>TM</sup> MAb-B43.13 in a Human-PBL-SCID/BG Mouse Model Birgit C. Schultes, Chengsheng Zhang, A.A. Noujaim, Hybridoma	1999	33
The role of transferrin in the in vivo uptake of gallium-67 in a canine tumor Hong-Nei Wong, U.K. Terner, Diana P. English, International Journal of Nuclear Medicine and Biology Tumor BiologyCanine TumorMedicinePathologyRadiopharmaceutical Therapy	1980	32

Page 1